Hospital Resource Use

TARGAXAN^® has been shown to reduce the burden on healthcare systems when used to prevent the recurrence of overt hepatic encephalopathy ^1‑3

The use of rifaximin-α to manage UK & Irish patients with hepatic encephalopathy has shown reductions in hospital resource utilisation. Select a parameter to find out more.